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A B S T R A C T
Cryptococcus neoformans is a human fungal pathogen that often causes infections in immunocompromised in-
dividuals. Upon inhalation into the lungs C. neoformans diﬀerentiates into cells with altered size and mor-
phology, including production of large titan cells. Titan cells possess thickened cell wall and dense, cross-linked
capsule when compared to in vitro grown cells. In addition, titan cells have increased cell wall chitin that is
associated with a detrimental anti-inﬂammatory immune response. Here we examined the cell wall and capsule
composition of in vitro, in vivo typical-sized and in vivo titan cells using High Performance Liquid
Chromatography (HPLC). The monomer composition of cell wall polysaccharides showed that in vivo C. neo-
formans cells contained more glucosamine and less glucose than in vitro cells, suggesting alteration in abundance
of both chitin and glucans, respectively. Low levels of galactosamine were also detected in carbohydrates from
both in vivo and vitro cells. Within the in vivo cell population, diﬀerences in the proportions of cell wall and
capsule monomers between typical and titan cells were also observed. Taken together, these results demonstrate
that C. neoformans reshapes its cell wall and capsule composition during infection. These cell wall and capsule
alterations likely help C. neoformans escape recognition by, and allow modulation of, the host immune system.
Introduction
Cryptococcosis is a life-threatening infection caused by Cryptococcus
neoformans and often observed in immunocompromised individuals
including patients with HIV/AIDS, cancer chemotherapy patients and
organ transplant recipients (Mitchell and Perfect, 1995, Park et al.,
2009, Jarvis et al., 2010). Even though the absolute number of Cryp-
tococcus-related deaths has declined since previous estimates, crypto-
coccal meningitis still causes 15% of all HIV/AIDS-related deaths
globally (Rajasingham et al., 2017). In Sub-Saharan Africa alone, the
region with the greatest burden, cryptococcal meningitis kills around
140,000 people per year and global mortality is estimated at around
181,000 people (Rajasingham et al., 2017).
A critical step during cryptococcal infection involves the formation
of enlarged cells called “titan cells” (Okagaki et al., 2010, Zaragoza
et al., 2010). While typical C. neoformans cells are 5–7 µm in diameter,
the titan cells can be up to 100 µm in diameter (Okagaki et al., 2010;
Zaragoza et al., 2010). Titan cells are also characterized by their in-
creased DNA content, thick cell wall, and a signiﬁcantly denser
crosslinked capsule (Okagaki et al., 2010; Zaragoza et al., 2010).
Changes in titan cell walls are important for survival of C. neoformans
within the host, and increased chitin content in titan cell wall signals
the host immune system to generate a detrimental immune response
that promotes disease progression in mice (Wiesner et al., 2015).
However, it is not known whether there are other in vivo cell wall
changes in titan or typical cells, and how these changes might aﬀect
C. neoformans pathogenesis.
Mammalian cells lack a cell wall; therefore, the fungal cell wall is an
ideal target for development of antifungal drugs. In fungi, the cell wall
plays important roles including protecting the cell from osmotic pres-
sure, various environmental stresses, and is also involved in interaction
between the fungal cell and its environment (Bowman and Free, 2006;
Erwig and Gow, 2016). C. neoformans also possesses a polysaccharide
capsule that is attached to the cell wall and covers its cell body
(Zaragoza et al., 2009). The presence or absence of capsule, as well as
its size and structure depends on diﬀerent environmental stimuli such
as temperature, growth medium, pH, the presence of CO2, and infected
organ type (Rivera et al., 1998; Zaragoza and Casadevall 2004; O’Meara
https://doi.org/10.1016/j.tcsw.2017.12.001
Received 12 August 2017; Received in revised form 5 December 2017; Accepted 31 December 2017
⁎ Corresponding author at: 689 23rd Avenue SE, Minneapolis, MN 55455, USA.
1 Current address: Department of Pediatrics, University of Wisconsin, Madison, WI, USA.
E-mail address: knielsen@umn.edu (K. Nielsen).
The Cell Surface 1 (2018) 15–24
Available online 16 February 2018
2468-2330/ © 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
and Alspaugh, 2012). Capsule polysaccharides can be divided into two
groups; those attached to the cell wall and exopolysaccharides that are
secreted into the surrounding environment or culture media (Zaragoza
et al., 2009). Exopolysaccharides are composed of 90–95% glucur-
onoxylomannan (GXM), 5–8% glucuronoxylomannogalactan
(GXMGal), and a few mannoproteins (Juneann, 1988; Cherniak and
Sundstrom, 1994, Vaishnav et al., 1998; Bose et al., 2003; McFadden
et al., 2006; Heiss et al., 2009; Zaragoza et al., 2009). Most of the
known information on cryptococcal capsule comes from studies that
examined the polysaccharides recovered from culture media (Turner
et al., 1992; Cherniak and Sundstrom, 1994, Cleare and Casadevall,
1999; McFadden et al., 2006; Heiss et al., 2009; Zaragoza et al., 2009),
however one study showed that the attached capsule is diﬀerent from
polysaccharides secreted to the environment (Frases et al., 2008). In
addition, most, if not all, previous studies used Cryptococcus cells gen-
erated in in vitro conditions. The exact structure and composition of
Cryptococcus capsule during infection is not well understood.
The composition and organization of individual cell wall compo-
nents can vary depending on the fungal species, growth conditions and
the stage of growth (Reiss et al., 1986; Abad et al., 2010; Gow et al.,
2011). The cell wall of C. neoformans is mainly composed of α- and β-
glucan, chitin and its deacetylated form chitosan (Reiss et al., 1986;
Banks et al., 2005; Baker et al., 2007; Reese et al., 2007; Baker et al.,
2011). In addition to these main components, the cell wall of C. neo-
formans also contains melanin, lipids and mannoproteins (Vartivarian
et al., 1989; Wang et al., 1995; Siafakas et al., 2007). However, this
information comes mainly from in vitro studies that used acapsular
mutant strains or strains with mutations impacting the cell wall (Reiss
et al., 1986; James et al., 1990; Reese et al., 2007). Acapsular mutants
were used to avoid contamination from the capsule polysaccharides
that are normally attached to the outer layer of the C. neoformans cell
wall. This is not ideal as acapsular mutant strains are avirulent in mice
(Fromtling et al., 1982; Chang and Kwon-Chung, 1994), and could
possess additional defects in their cell wall structure. Thus, the com-
plete cell wall composition of a wild-type C. neoformans strain is cur-
rently not known, and the potential for cell wall remodeling under
diﬀerent growth conditions has not been explored.
Modiﬁcation of the cell wall composition/structure likely con-
stitutes a crucial step in the initial establishment and maintenance of C.
neoformans infection (Okagaki et al., 2010; Zaragoza et al., 2010;
Okagaki and Nielsen, 2012; Zaragoza and Nielsen, 2013; Wiesner et al.,
2015). Except for preliminary studies examining chitin content in titan
cells, it is not known how other cell wall changes, if any, in in vivo C.
neoformans cells (both titan and typical cells) aﬀect C. neoformans pa-
thogenesis and the host immune response. The aim of this study was to
identify the cell wall composition of both in vitro grown and in vivo cells,
both titan and typical cells, of a wild type strain of C. neoformans.
Materials and methods
Ethics statement
Mice were handled in accordance with guidelines deﬁned by the
University of Minnesota Animal Care and Use Committee (IACUC). All
animal experiments were done in concordance with the Animal Welfare
Act, United States federal law, and NIH guidelines.
Strains and media
C. neoformans KN99α (WT) (Nielsen et al., 2003), and acapsular C.
neoformans cap67 and cap59 mutant strains (Jacobson et al., 1982;
Chang and Kwon-Chung, 1994) were used in this study. Strains from
stored glycerol stocks (kept at−80 °C) were grown at 30 °C for 24–48 h
on yeast-peptone-dextrose (YPD) (BD, Hercules, CA). C. neoformans
cells from the YPD agar plate were transferred to YPD broth and grown
overnight at 30 °C.
Production and isolation of titan and typical cells
C. neoformans titan and typical cells were produced as previously
described (Okagaki et al., 2010; Wiesner et al., 2015). Brieﬂy, overnight
YPD-grown C. neoformans cells were collected by centrifugation, wa-
shed twice with sterile phosphate-buﬀered saline (PBS) and re-
suspended in sterile PBS at a concentration of 1×106 cells/ml based on
hemocytometer count. Groups of 6–8-week-old female A/J mice
(Jackson Laboratory, Bar Harbor, MA) were anesthetized by in-
traperitoneal pentobarbital injection and infected intranasally with
5×104 cells in 50-µl PBS. At 14 days post-infection, mice were sacri-
ﬁced by CO2 inhalation. The lungs were harvested and then homo-
genized in 10ml PBS supplemented with collagenase (1mg/ml)
(Zaragoza et al., 2010). Cell homogenates were incubated for 1 h at
37 °C with agitation, and washed several times with double distilled
water. The C. neoformans cells were resuspended in sterile double dis-
tilled water.
To separate titan and normal-sized (which we refer to as “typical”)
cell populations, we used a previously described method (Gerstein
et al., 2015). As previously, C. neoformans cells (mixture of titan and
typical cells) from lung homogenates were ﬁltered using CellMicro-
Sieves (BioDesign Inc. of New York, Carmel, NY) with a 20-µm pore size
that allows typical cells to pass through the membrane. The CellMi-
croSieves were then rinsed with sterile PBS to remove any remaining
typical cells from the ﬁlter. To recover the titan cell population, the
CellMicroSieves were inverted and the membrane was washed with
PBS. The resulting cell populations was concentrated by centrifugation
at 12,000×g for 1min.
γ-Radiation treatment
In vivo C. neoformans cells with enlarged capsule were exposed to γ-
radiation to remove layers of the capsule polysaccharide as described
previously with the following modiﬁcations (Zaragoza et al., 2010).
Cells isolated from the lungs of infected mice were washed in PBS and
resuspended in sterile double distilled water. The cells were then
transferred to a 24-well ﬂat-bottom plate and irradiated for 45min for a
total irradiation dose of 560 Gy (56,000 rad). After irradiation, cell
suspensions were transferred into Eppendorf tubes, centrifuged, and the
supernatant was separated from the irradiated cell pellet by cen-
trifugation. The supernatant containing capsule polysaccharide was
freeze-dried and stored at −20 °C until further analysis. The irradiated
cell pellet was used in cell wall extraction experiments.
Cell wall and capsule extraction
Cell wall/capsules were extracted using a modiﬁed version of pre-
viously described methods (Munro et al., 2003; Mora-Montes et al.,
2007; Mora-Montes et al., 2012). Brieﬂy, C. neoformans cells were ei-
ther grown in YPD medium or isolated from lungs of infected mice as
described above. Cells were washed with sterile double distilled water
and broken with glass beads using a BIO101/Savant FastPrep FP120
machine (20 cycles of 45 s each cycle, at a speed of 4m/s). The
homogenates were centrifuged at 4000 rpm for 5min, and the pellet
(broken cells) was washed 5 times with 1M NaCl, resuspended in buﬀer
(500mM Tris–HCl buﬀer [pH 7.5], 2% [wt/vol] SDS, 0.3M β-mer-
captoethanol, 1 mM EDTA) and boiled twice at 100 °C for 10min. Ex-
tracted cell wall pellet was collected, washed with sterile double dis-
tilled water, freeze dried and the dry weight of recovered cell walls was
recorded.
Hydrolysis of cell wall/capsule polysaccharides
Puriﬁed cell wall/capsule was hydrolyzed using a modiﬁcation of
several previously described methods (Morrison, 1988; Mora-Montes
et al., 2007; Mora-Montes et al., 2012). Six diﬀerent approaches were
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used to hydrolyze cell wall/capsule polysaccharide (Table 1).
Approaches 1 and 2
Triﬂuoroacetic acid (TFA) (0.75 ml) was added to dried cell wall/
capsule polysaccharides in 1.5 ml screw-cap tubes (SARSTEDT) and
incubated at 37 °C for 20 h (approach 1) or at 100 °C for 3 h (approach
2), then evaporated to dryness at 70–80 °C in a thermal block. After all
acid was evaporated, double distilled water (1.0 ml) was added to each
sample as a washing step, and mixed by pipetting. Samples were then
evaporated to dryness by incubating open tubes at 70–80 °C. Dried
hydrolyzed samples were stored at -20 °C until analyzed by High
Performance Anion-Exchange Chromatography with Pulsed
Amperometric Detection (HPAEC-PAD).
Approaches 3–7
TFA (0.75ml) was added to dried cell wall/capsule polysaccharide
and incubated at 37 °C for 20 h. Aliquots (0.375ml) were transferred to
two new tubes and myo-inositol (1.125ml, 0.75mg/ml) was added to
each tube as a positive control to conﬁrm hydrolysis. Preliminary stu-
dies comparing the addition of water versus myo-inositol showed no
eﬀect of the myo-inositol addition on other components within the
reaction (data not shown). One aliquot was heated at 100 °C for 30min
(approach 3), and the other heated at 100 °C for 3 h (approach 4) or for
4 h (approach 5). Both samples were then evaporated to dryness. After
all acid was evaporated, double distilled water (1.0 ml) was added to
each sample as a washing step, and mixed by pipetting. Samples were
then evaporated to dryness by incubating tubes at 70–80 °C. Dried hy-
drolyzed samples were stored at−20 °C until analyzed by HPAEC-PAD.
Approaches 6 and 7 were similar to approaches 3 and 4 except that the
dried cell wall/capsule polysaccharides were resuspended in TFA and
incubated at 37 °C for 72 h, instead of 20 h, before being incubated at
100 °C for 30min and 3 h respectively.
Carbohydrate quantiﬁcation by HPAEC-PAD
The hydrolyzed cell wall/capsule samples were analyzed by HPAEC-
PAD as previously described with minor modiﬁcations (Munro et al.,
2003; Mora-Montes et al., 2007; Mora-Montes et al., 2012). For
monosaccharide analysis of the Cryptococcus cell wall component, 10 µl
aliquots of acid-hydrolyzed samples were injected in a Dionex HPAEC
system equipped with a CarboPac SA-10 analytical column
(4× 250mm) and a CarboPac SA-10 guard column (4×50mm). The
CarboPac SA-10 analytical column was used because the most com-
monly used CarboPac PA-10 column was unable to separate xylose and
mannose (Supplemental Table 1 and Supplemental Fig. 1). Samples
were eluted with 12mM NaOH at a ﬂow rate of 1.2 ml/min for 10min.
The column was washed with 100mM NaOH for 5–10min and equili-
brated with 12mM NaOH for 10min prior to the next run. Mono-
saccharides were detected by their oxidation at a gold electrode surface
of the PAD. Seven monomers were used as standards: D-fucose, D-glu-
cose, D-glucosamine, D-mannose, D-galactose, D-galactosamine, and D-
xylose. The monomer standards were dissolved in double distilled water
and run under the same conditions. Myo-inositol was used as a hy-
drolysis control for Approaches 3–7.
Results
Detection of C. neoformans carbohydrates depends on the method used
To analyze the total C. neoformans cell surface carbohydrate con-
tent, we used a wild type strain, KN99α, that is virulent in the mouse
model of infection (Nielsen et al., 2003). Using previously described
methods (Munro et al., 2003; Mora-Montes et al., 2007; Mora-Montes
et al., 2012), we measured the total carbohydrate content of C. neo-
formans cells from in vitro cultures and from lungs of infected mice (in
vivo cells). The major characteristic diﬀerentiating in vivo and in vitro-
grown cells is the presence of a large capsule surrounding the C. neo-
formans cell body in vivo (Fig. 1A). C. neoformans capsule is pre-
dominantly composed of GXM and GXMGal polysaccharides (Frases
et al., 2008; Zaragoza et al., 2009). Preliminary analysis of carbohy-
drates of both in vitro and in vivo cells identiﬁed diﬀerent proportions of
glucosamine, glucose and mannose in the two cell populations
(Fig. 1B). However, monosaccharides such as galactose and xylose that
would be expected to come from in vivo capsule were not detected
(Fig. 1B). Diﬀerent hydrolysis methods that varied the temperature and
time of hydrolysis were tested to optimize detection of all expected
monosaccharides (Table 1). These experiments showed that hydrolysis
for 20 h at 37 °C followed by a 30-min incubation at 100 °C (Approach
3) recovered all carbohydrates expected to be present in the cell wall
and capsule of C. neoformans (Table 1). In addition, a CarboPac SA 10
column was needed to diﬀerentiate galactose, galactosamine, glucose,
glucosamine, mannose, and xylose simultaneously (Supplemental
Table 1 and Supplemental Figs. 1 and 2).
We next measured the carbohydrate content of the wild type strain
(KN99α) and the previously used acapsular mutants cap67 and cap59
grown in the same in vitro conditions. The results show that, when
grown in vitro, C. neoformans KN99α, cap67 and cap59 strains had si-
milar glucosamine (monomer component of cell wall chitin and chit-
osan), and glucose (monomer component of α- or β-glucans) (Fig. 2A
and B). The mannose content was signiﬁcantly higher in the wild type
strain compared to the acapsular mutant strains (Fig. 2C). Low levels of
galactose and xylose (components of GXM and GXMGal) were detected
in the wild type strain and, as expected, xylose was absent in the
acapsular mutant strains (Fig. 2D and E). Surprisingly, low levels of
galactose, a component of the capsular GXMGal were detected in the
acapsular mutants (Fig. 2E). Very low levels (less than 0.1% of total
carbohydrate content) of galactosamine were also detected in both the
wild type and acapsular mutants, with acapsular mutants having more
galactosamine than the wild type strain (data not shown). These results
show that KN99α, cap67 and cap59 strains have overall similar cell wall
carbohydrate composition when grown in vitro. As the wild type strain
is known to form a small capsule in vitro (Fig. 1A), the presence of
Table 1
Cell wall hydrolysis approaches.
Hydrolysis method Carbohydrates detected (μg/mg of dry cell wall)
Step-1 at 37 °C Step-2 at 100 °C Glucosamine Glucose Mannose Xylose Galactose Total (μg/ml)
Approach -1 (N=6) – 3 h 7.3 ± 1.1 130.4 ± 34.1 9.7 ± 3.9 ND ND 147.3 ± 38.2
Approach -2 (N=4) 20 h – 0.6 ± 0.5 76.7 ± 7.9 4.2 ± 1.5 ND ND 81.5 ± 9.0
Approach -3 (N=5) 20 h 30min 6.5 ± 1.2 415.0 ± 78.6 39.1 ± 5.6 7.0 ± 2.7 1.1 ± 0.7 468.7 ± 83.6
Approach -4 (N=5) 20 h 3 h 11.3 ± 0.5 625.9 ± 19.8 55.5 ± 8.6 ND 3.6 ± 1.5 696.3 ± 20.3
Approach -5 (N=5) 20 h 4 h 6.5 ± 1.6 266.8 ± 39.7 24.8 ± 12.4 0.4 ± 0.2 ND 348.4 ± 62.6
Approach -6 (N=2) 72 h 30min 1.3 ± 0.5 77.0 ± 1.2 ND 0.9 ± 0.1 ND 79.2 ± 0.6
Approach -7 (N=3) 72 h 3 h 5.1 ± 1.2 154.7 ± 35.7 2.2 ± 1.4 ND ND 162.0 ± 33.2
ND: not detected.
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xylose in the wild type, but not in the acapsular mutant strains indicates
that xylose is mainly a capsular component. The presence of galactose
in the acapsular cell wall extracts could be because the GXMGal was
secreted into the environment or was still loosely attached to the cell
wall in these mutants, as previously suggested (Turner et al., 1984;
Cherniak, 1988).
Diﬀerences in C. neoformans cell wall composition in vitro and in vivo
C. neoformans titan cells from in vivo mouse models possess a thicker
cell wall compared to in vitro grown cells (Zaragoza et al., 2010). Fur-
thermore, we previously showed that titan cells have increased cell wall
chitin compared to in vivo typical cells (Wiesner et al., 2015). However,
it was not known whether other cell wall components also change in in
vivo C. neoformans cells. We used hydrolysis approach-3 to measure the
cell wall composition of the wild type strain KN99α grown in vitro, and
isolated from the lungs of infected mice. In vivo cells contained sig-
niﬁcantly higher glucosamine and less glucose than in vitro grown cells
(Fig. 3A and B). In vivo cryptococcal cells also contained increased
mannose and xylose compared to in vitro grown cells (Fig. 3C and D).
Galactose content was slightly higher in in vitro cells than in in vivo cells
(Fig. 3E). To determine whether these diﬀerences were due to the
capsule on the in vivo cells, we also analyzed the cell wall composition
of irradiated in vivo cells in which most of the capsule was removed
(Fig. 4). Irradiated in vivo cells contained similar mannose and xylose as
the in vitro cells (Fig. 3C and D), showing the increase in these com-
ponents in the non-irradiated in vivo cells was due to additional capsule
formation. Galactose was not detected in irradiated cells suggesting that
galactose is a capsular component that was removed by the irradiation
(Fig. 3E).
These data show that in vivo and in vitro cells have diﬀerent cell wall
and capsule composition (Fig. 3A–E). In vivo cells have increased glu-
cosamine and decreased glucose indicating higher chitin and lower
glucan content of the in vivo cell wall compared to the in vitro cell wall.
In addition, the in vivo cells have a thickened capsule with increased
levels of mannose, xylose and galactose when compared to in vitro cells.
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Fig. 1. Total carbohydrate content of in vitro and in vivo C. neoformans cells. A, In vitro-
grown and in vivo C. neoformans cells stained with India ink. B, Carbohydrate content of in
vitro and in vivo C. neoformans cells. C. neoformans KN99α strain was grown in vitro
overnight at 30 °C in YPD broth, or isolated from the lungs of infected mice at 14 days
post-infection. Cell walls were extracted, freeze-dried and hydrolyzed with TFA for 3 h at
100 °C. Glucosamine, glucose, mannose, galactose and xylose were quantiﬁed using high-
performance anion-exchange chromatography with pulse amperometric detection
(HPAEC-PAD). Data represent means of results from 2 independent biological replicates
(N=6 for in vitro samples, and N=8 for in vivo samples). ND: not detected, YPD: yeast-
peptone-dextrose, CW: cell wall. Scale bar=10 μm.
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Fig. 2. Cell wall composition of in vitro grown C. neoformans KN99α, cap67 and cap59 strains. C. neoformans KN99α, cap67 and cap59 strains were grown in vitro overnight at 30 °C in YPD
broth. Cell walls were extracted, freeze-dried and hydrolyzed with TFA. Absolute monosaccharide amounts are expressed as micrograms per 1mg of dry weight. Relative carbohydrate
content expressed as percentages of the recovered total carbohydrate materials. Glucosamine (A), glucose (B), mannose (C), xylose (D), and galactose (E) were quantiﬁed using HPAEC-
PAD. Data represent mean of results from at least 3 replicates (N=5 for KN99α, N=3 for cap67 and cap59). T-test was used to compare mean of the wild type (WT) strain to those of
acapsular mutants. *P < 0.05, **P < 0.01. YPD: yeast-peptone-dextrose, ND: not detected.
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Titan and typical C. neoformans cells have diﬀerent cell wall composition
In vivo C. neoformans cells vary in size, from cells less than 3 μm in
cell body diameter to cells more than 100 μm in diameter (Feldmesser
et al., 2001; Okagaki et al., 2010; Zaragoza et al., 2010; Alanio et al.,
2015). The in vivo C. neoformans cells were divided into two groups;
typical cells (less than 10 μm of cell body diameter), and titan cells
greater than 10 μm in cell body diameter. The titan cell population has
increased DNA content, a dense cross-linked capsule and thick cell wall
(Okagaki et al., 2010; Zaragoza et al., 2010). We examined the cell wall
composition of both typical and titan cells after γ-irradiation to remove
most of the capsule. Glucosamine was signiﬁcantly increased in titan
cell walls compared to typical cells (Fig. 5A), conﬁrming previous
studies showing increased levels of chitin in titan cells (Wiesner et al.,
2015). While the absolute glucose content was higher in titan cells
(Fig. 5B), the relative cell wall glucose content as percentage of the total
recovered cell wall material decreased in titan cells (78.5%) compared
to typical cell walls (93.8%) (Fig. 5B). The cell wall of titan cells also
contained signiﬁcantly higher mannose and xylose (Fig. 5C and D).
Galactose was not detected in these γ-irradiated cell wall samples
(Fig. 5E), suggesting no GXMGal capsule component remained asso-
ciated with the cell wall after γ-irradiation. The detected mannose and
xylose could be structural components of the actual C. neoformans cell
wall, cell wall mannoproteins, or the small portion of the capsule still
attached to the irradiated C. neoformans cells (Fig. 4), also described
previously (Zaragoza et al., 2010).
Capsule composition diﬀerences between titan and typical cells
Treatment of C. neoformans cells with γ radiation removes most of
the capsule (Fig. 4). We analyzed the composition of this dissociated
capsule from in vivo typical and titan cells. Glucosamine was not de-
tected in the dissociated capsule of either titan or typical cells (Fig. 6A),
suggesting the capsule preparation was not contaminated with cell wall
debris. Analysis of the dissociated capsule revealed that titan cell cap-
sule contained signiﬁcantly higher relative mannose content than that
of typical cells (Fig. 6C). Conversely, the relative amount of glucose and
galactose decreased in the capsule of titan cells compared to typical
cells, although this diﬀerence was not signiﬁcant when absolute values
were compared (Fig. 6B and E). Absolute xylose content was increased
in the titan cell capsule (Fig. 6D), however the relative xylose content
(percentage) was not signiﬁcantly diﬀerent from typical cells (15.1% vs
15.7% respectively) (Fig. 6D). These results show that, in addition to
the cell wall composition, capsule composition diﬀers between titan
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Fig. 3. Diﬀerences between cell wall and capsule carbohydrate composition of in vivo and in vitro C. neoformans cells. C. neoformans KN99α strain was either grown in vitro overnight at
30 °C in YPD broth, or isolated from lungs of infected mice. A portion of the in vivo C. neoformans cell sample was treated with γ-radiation for 45min to remove the capsule poly-
saccharides. Cell walls were extracted from irradiated and non-irradiated C. neoformans cells, freeze-dried and hydrolyzed with TFA. Absolute monosaccharide amounts are expressed as
micrograms per 1mg of dry weight. Relative carbohydrate content is expressed as percentage of the recovered total cell wall material. Glucosamine (A), glucose (B), mannose (C), xylose
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Non-irradiated 
Irradiated 
Titan cells Typical cells
Fig. 4. Irradiation removes C. neoformans capsule. C. neoformans KN99α cells were iso-
lated from the lungs of infected mice 14 days after infection. A portion of the cell sample
was treated with γ-radiation (560 Gy) for 45min to remove capsule polysaccharides. Both
irradiated and non-irradiated cells were stained with India ink, and imaged using dif-
ferential interference contrast (DIC). Scale bar= 10 μm.
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and typical cells, with titan cells containing higher mannose and xylose
than typical cells.
Discussion
Morphology changes play an important role in the initiation and
maintenance of C. neoformans infections. During infection, C. neofor-
mans cells of varying cell body size and capsule size are observed
(Feldmesser et al., 2001; Okagaki et al., 2010; Zaragoza et al., 2010;
Alanio et al., 2015). These structural and morphological characteristics
allow C. neoformans to evade and modulate the host immune system
(Almeida et al., 2001; Okagaki and Nielsen 2012; Wiesner et al., 2015).
We previously showed that increases in chitin, a C. neoformans cell wall
component, during titan cell formation induces a detrimental Th2 im-
mune response in mice (Wiesner et al., 2015). However, it was not
known if there are other cell wall changes in in vivo C. neoformans. Here
we examined the cell wall composition of both in vitro-grown and in vivo
C. neoformans cells to identify changes that occur when C. neoformans
transitions from in vitro to in vivo growth conditions. Cell walls of C.
neoformans cells from infected mice contained signiﬁcantly higher
glucosamine, and lower glucose than the cell wall of in vitro-grown
cells. In addition to diﬀerences between in vitro and in vivo cell walls, we
found that in vivo titan cells have a diﬀerent cell wall composition than
that of in vivo typical cells. Titan cell walls contained higher glucosa-
mine, mannose and xylose than typical cells.
The HPLC analysis used here identiﬁed changes in the total carbo-
hydrate content between diﬀerent C. neoformans cell types. However,
this technique cannot determine the origin of the observed changes for
speciﬁc polysaccharides with similar monomer carbohydrate compo-
nents. For example, we observed that the cell wall glucosamine content
increased in in vivo C. neoformans cells, but HPLC cannot determine
whether these changes in glucosamine come from changes in chitin,
chitosan, chito-oligomers, or glucosamine-derived polysaccharides. We
also observed changes in total cell surface glucose and mannose con-
tent. Similarly, our method cannot specify if these carbohydrate
changes reﬂect changes in α- or β-glucans, or changes in cell wall
mannans, mannoproteins, or capsule components (GXM, GXMGal)
trapped in the cell wall, respectively. In spite of these limitations, this
study identiﬁed substantial cell surface modiﬁcations that occur during
C. neoformans infection and likely dramatically impact the way C.
neoformans is perceived by the host immune system.
The increase in total glucosamine in in vivo cell wall, especially in
titan cells, supports our previous observation using diﬀerent methods
(Wiesner et al., 2015) that C. neoformans has increased chitin (polymer
of N-acetylglucosamine) in vivo. This increase in chitin correlates with a
detrimental Th2 immune response in mice (Wiesner et al., 2015). In
addition, the glucosamine-derived molecules chitin and chitosan are
known to play key roles in cell wall integrity, capsule structure/at-
tachment to the cell wall, and in the virulence of C. neoformans (Baker
et al., 2007; Rodrigues et al., 2008; Fonseca et al., 2009; Baker et al.,
2011; Wiesner et al., 2015). Thus, modiﬁcation of in vivo C. neoformans
not only changes cell wall composition but also interactions with the
host immune system and the resulting immune response.
Increase in fungal cell wall chitin can also aﬀect how the fungus
reacts to antifungal drugs. In another fungal pathogen, Candida albi-
cans, increased chitin is associated with increased resistance to echi-
nocandins, a class of antifungal drugs targeting cell wall β,1–3 glucans
(Walker et al., 2010). The observed increase in in vivo cell wall gluco-
samine, and decreased glucose mirror cell wall changes observed when
C. albicans is treated with Caspofungin, an antifungal that inhibits cell
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Fig. 5. Cell wall composition of C. neoformans typical and titan cells. C. neoformans KN99α cells were isolated from lungs of infected mice. Titan cells were separated from typical cells by
ﬁltration and treated with γ-radiation for 45min to remove capsule polysaccharides. Cell walls were extracted from irradiated C. neoformans cells, freeze-dried and hydrolyzed with TFA.
Absolute monosaccharide amounts are expressed as micrograms per 1mg of dry weight. Relative carbohydrate content is expressed as percentage of the total recovered cell wall material.
Glucosamine (A), glucose (B), mannose (C), xylose (D), and galactose (E) were quantiﬁed using HPAEC-PAD. Data represents the mean of 4 replicates per group. T-test was used to
compare mean carbohydrate composition of typical and titan cell walls. *P < 0.05, **P < 0.01, ***P= <0.001. TFA: triﬂuoroacetic acid, ND: not detected.
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wall β,1–3 glucan synthesis (Walker et al., 2008), and likely explains
why echinocandin drugs show promising anti-cryptococcal activity in
vitro (Bartizal et al., 1997; Franzot and Casadevall, 1997), but are in-
eﬀective in vivo (Abruzzo et al., 1997).
Glucans are polysaccharides of glucose monomers, and the cell wall
of C. neoformans is composed of both α- and β-glucans (Bacon et al.,
1968; James et al., 1990; Reese et al., 2007). In our experiments, we
showed that in vivo cell wall contains less glucose than in vitro cell wall,
and titan cell wall contained less glucose than typical cell wall. Cell wall
α-glucans are important for capsule attachment to the C. neoformans
cell body (Reese and Doering, 2003). Disrupting α-1,3-glucan produc-
tion in C. neoformans produces cells that shed capsule material into the
environment but lack the surface capsule normally attached to the cell
body (Reese and Doering, 2003; Reese et al., 2007). Titan cells have a
thick and highly cross-linked capsule attached to their cell wall (Fig. 7
and (Zaragoza et al., 2010)). Thus, the reduction we see in total glucose
content of the titan cell wall is unlikely due to a lack of α-glucans as
capsule attachment appears to be unaﬀected. C. neoformans cell wall
also contains two types of β-glucans; β-1,3-glucans and β-1,6-glucans
(James et al., 1990; Feldmesser et al., 2000). The proportion of each β-
glucan type can change depending on the cryptococcal strain, growth
condition, and exposure to caspofungin, an antifungal drug that targets
β-1,3-glucans (Feldmesser et al., 2000). The speciﬁc function of β-1,6-
glucan in the C. neoformans cell wall is not well understood, but dis-
ruption of β-1,6-glucan production results in capsules that are enlarged,
more diﬀuse, and more permeable than wild type cells (Gilbert et al.,
2010). In vivo titan cells have large cross-linked capsules with reduced
permeability (Zaragoza et al., 2010), suggesting that β-1,6-glucans are
either unaﬀected or increased in our in vivo samples. Fungal β-glucans
are recognized by the Dectin-1 receptor of host immune cells (Brown
et al., 2003; Gow et al., 2007). Fungal pathogens such as C. albicans are
known to evade Dectin-1 recognition by switching to hyphal forms that
do not expose β-glucans at the cell surface (Gantner et al., 2005). Si-
milarly, our data show C. neoformans cell wall contains lower glucan
levels, which likely explains why Dectin-1 receptor has no function in
the immune response to C. neoformans (Nakamura et al., 2007). The
combination of low glucan in in vivo cell walls and a thick capsule likely
reduce the surface exposure of β-glucans on in vivo C. neoformans cells
and prevent direct contact between β-glucans and the Dectin-1 re-
ceptor. Direct contact between Dectin-1 receptor and the microbial
surface, not soluble ligands, is required for the activation of the re-
ceptor and subsequent signaling (Goodridge et al., 2011; Lin et al.,
2016).
Large increases in mannose were detected in the titan cell wall, and
could be components of cell wall mannans, mannoproteins, or capsule
components trapped in the cell wall during extraction. Mannoproteins
are located in the inner layer of the C. neoformans cell wall (Vartivarian
et al., 1989). These mannoproteins were suggested to be non-structural
cell wall components that eventually migrate to the cell surface, and are
secreted in the environment (Vartivarian et al., 1989). Mannoproteins
are also found in the supernatant and cell wall extracts from in vitro C.
neoformans cultures, and small amounts of mannose were found among
monosaccharides extracted from C. neoformans cells (Murphy et al.,
1988; James et al., 1990; Levitz et al., 2001; Park et al., 2012). Mannose
detected in titan cell walls accounted for approximately 12% of the
total cell wall. This amount seems high for residual capsule GXM and
GXMGal transiting the cell wall for subsequent secretion. An alternate
hypothesis is that titan cell walls contain a signiﬁcant amount of
mannoproteins or structural mannans. The presence of signiﬁcant
mannoprotein fractions in the cell walls could also explain the presence
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Fig. 6. Typical and titan capsule composition. C. neoformans KN99α cells were isolated from lungs of infected mice. Titan cells were separated from typical cells by ﬁltration and treated
with γ-radiation for 45min to remove the capsule polysaccharides. The dissociated capsule was collected in the supernatant, freeze-dried and hydrolyzed with TFA. Absolute mono-
saccharide amounts were expressed as micrograms per 1mg of dry weight. Relative carbohydrate content is expressed as percentage of the total recovered capsule material. Glucosamine
(A), glucose (B), mannose (C), xylose (D), and galactose (E) were quantiﬁed using HPAEC-PAD. Data represent mean of at least 3 replicates in each group. (N=4 for typical cells and
N=3 for titan cells). T-test or Mann-Whitney test were used to compare mean carbohydrate composition of the capsule of typical and titan cells. *P < 0.05, **P < 0.01. TFA:
triﬂuoroacetic acid, ND: note detected.
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of xylose as previous studies showed that C. neoformans mannoproteins
might contain xylose and xylose-phosphate structures (Reilly et al.,
2011; Park et al., 2012). Some mannoproteins are recognized as pri-
mary cryptococcal antigens (Murphy et al., 1988; Levitz et al., 2001;
Mansour et al., 2002), while other mannoproteins such as MP4 and
App1 dampen the host immune response against C. neoformans
(Coenjaerts et al., 2001; Luberto et al., 2003). During infection, titan
cells confer protection from phagocytosis to the entire cryptococcal
population (Crabtree et al., 2012; Okagaki and Nielsen, 2012). Whether
this protection is associated with increased production of speciﬁc
mannoproteins and their impact on immune responses poses an intri-
guing idea. Finally, and perhaps most intriguing is the possibility that
titan cells contain increased structural mannans. Studies in both Pneu-
mocystis and C. albicans have revealed structural mannan layers that
generate distinct vertical ﬁbral structures when imaged by electron
microscopy (EM) (Gow et al., 2011; Erwig and Gow, 2016; Ma et al.,
2016). EM images of titan and typical cell walls (Fig. 7) show similar
vertical structures on the exterior surface of the titan cell wall (adjacent
to the capsule), and these structures are absent in typical cells.
Capsule dissociated from titan cells contained more mannose, but
less galactose and glucose, than capsule from typical cells. All these
carbohydrate monomers were previously found to be components of the
Cryptococcus capsule (Cherniak and Sundstrom, 1994; Vaishnav et al.,
1998; Frases et al., 2008). Glucose represented up to 20% of capsule
dissociated from typical cells. This glucose may represent glucans re-
leased from the cell wall by γ-radiation treatment (Frases et al., 2008).
Alternatively, the glucose may be a structural component of the capsule
essential for the attachment of the capsule to the cell wall. Our ob-
servation that glucose levels were higher than xylose, a known capsule
component of GXM and GXMGal, and the absence of glucosamine in the
detached capsule argue for the latter hypothesis. Diﬀerences in capsule
polysaccharides between in vivo typical and titan cells may represent
diﬀerent epitopes between these two types of cells, and likely impact
how these two types of cells are perceived by and/or interact with the
host immune system.
In addition to the carbohydrate content of the known cell wall and
capsule polysaccharides, we observed smaller amounts of galactosa-
mine in both in vitro and in vivo cell extracts. To our knowledge
galactosamine has not been previously detected in C. neoformans cell
wall or capsule, although one study identiﬁed a UGT1 (UDP-galactose
transporter) gene responsible for the transport of both UDP-galactose
and UDP-galactosamine in vitro (Li et al., 2017). This ﬁnding together
with our observation suggest the presence of both galactose and ga-
lactosamine in C. neoformans polysaccharides. The signiﬁcance of this
observation in relation to possible diﬀerences in host immune response
remain to be explored. Studies in Aspergillus fumigatus found that ga-
lactosaminogalactan (GAG), a polysaccharide of galactose and N-acet-
ylgalactosamine, impacts the immune response (Fontaine et al., 2011;
Gravelat et al., 2013; Lee et al., 2015). This observation supports the
need to study galactosamine in C. neoformans and its potential role in
pathogenesis.
Our data, both EM images and HPLC analysis, and previous studies
support a model in which C. neoformans typical and titan cells possess a
diﬀerent cell surface (Fig. 7). Upon initial pulmonary infection, a subset
of C. neoformans cells diﬀerentiate into enlarged titan cells with a thick
cell wall and a highly crosslinked capsule (Feldmesser et al., 2001;
Okagaki et al., 2010; Zaragoza et al., 2010). The cell wall of C. neo-
formans is composed of (a) an inner cell wall layer that contains chitin/
chitosan, melanin and β-glucan, and (b) an outer layer that contains α-
glucans that mediate the attachment the capsule to the cell wall (James
et al., 1990; Nosanchuk et al., 2000; Rosas et al., 2000; Reese and
Doering, 2003; Banks et al., 2005; Baker et al., 2007; Reese et al., 2007,
Erwig and Gow, 2016). Titan cell walls contain increased chitin and
melanin and less β-glucan than typical cells (Fig. 5 and (Zaragoza et al.,
2010; Wiesner et al., 2015)). EM images suggest that titan cells, but not
typical cells, also possess structural mannan in their outer cell wall in
addition to α-glucans (Figs. 5 and 7). Lastly, our results suggest that
titan cells have increased capsule GXM, but similar GXMGal than ty-
pical cell capsule (Figs. 6 and 7). In addition to polysaccharides the C.
neoformans cell surface also contains proteins and lipids (Vartivarian
et al., 1989; Levitz et al., 2001; Djordjevic et al., 2005), however these
were not analyzed in the present study. The proposed model of in vivo
C. neoformans cell wall and capsule presented in Fig. 7 was deduced
from our observations, together with observations from earlier studies
that measured total carbohydrate content. The exact organization and
localization of individual cell wall and capsule components needs to be
Typical
Titan
GXM
GXMGal
Į-glucan
ȕ-glucan
Mannan
Protein
Melanin
Chitin
Membrane
Fig. 7. Schematic representation of C. neoformans typical and titan cell surface. Electron microscope (EM) images and schematic diagram of titan and typical cell wall and capsule. The
cell wall of C. neoformans is surrounded by a thick polysaccharide capsule composed of GXM and GXMGal. The cell wall is composed of polysaccharides arranged into inner and outer
layers. The inner wall contains chitin, chitosan, β-glucans, melanin and cell wall proteins. The outer layer is composed of α-glucans that mediate the attachment of the capsule to the cell
wall. Based on our ﬁndings, titan cells contain more chitin in their inner wall, and the outer wall of titan cell walls also have a layer of mannan ﬁbrils in addition to α-glucans. Attached to
α-glucans is the capsule that is more dense and highly cross-linked in titan cells than in typical cells. Scale bar= 1 μm.
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veriﬁed by further studies.
The in vivo cell surface analysis performed here was from C. neo-
formans cells isolated from the lungs of infected mice. Previous studies
speciﬁcally examining capsule structure have shown diﬀerences based
on anatomical location with diﬀerences in capsule structure of cells
grown in vitro and those isolated from the lungs, spleen, kidney, liver,
heart and brain of infected mice (Rivera et al., 1998; Charlier et al.,
2005). Further research is necessary to investigate whether similar cell
wall changes occur across diﬀerent organs. Importantly, we have shown
dramatic diﬀerences in the composition of the cell wall in vivo versus in
vitro, and between diﬀerent in vivo cell types that likely impact inter-
action with the host. Better understanding of how these diﬀerences
alter the host-pathogen interaction and the immune response will
highlight key changes necessary for C. neoformans pathogenesis.
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